MD — Pediatrix Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Pediatrix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,734	1,911	1,972	1,995	2,013
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,636	1,723	1,856	2,007	2,082
Operating Profit	98.1	188	116	-12.7	-68.7
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	7.15	135	81.4	-48.4	-101
Provision for Income Taxes
Net Income After Taxes	-9.58	108	62.6	-60.4	-99.1
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-796	131	66.3	-60.4	-99.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-796	131	66.3	-60.4	-99.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.46	1.55	1.51	0.614	0.78